Vimarsana
Biggest News Aggregation in the World

Page 19 - Breakthrough Devices Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Devices Program Today - Breaking & Trending Today

FDA-Purdue Double Agents? Big Business of Breakthrough Devices; Long COVID Runaround - Vimarsana News

FDA-Purdue Double Agents? Big Business of Breakthrough Devices; Long COVID Runaround

This past week in healthcare investigations

Brightline launches autism care program for caregivers and more digital health briefs - Vimarsana News

Brightline launches autism care program for caregivers and more digital health briefs

Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.

CMS is prioritizing healing heart valves over bolstering brain health - Vimarsana News

CMS is prioritizing healing heart valves over bolstering brain health

Our analysis demonstrates that CMS’s coverage processes for breakthrough devices demonstrate product class and disease state disparities. These disparities contradict mental health parity statute, CMS Administrator Brooks-LaSure’s focus on equity, and President Biden’s charge to improve brain health.

Mojo Vision takes another step toward AR contact lenses with new prototype – TechCrunch - Vimarsana News

Mojo Vision takes another step toward AR contact lenses with new prototype – TechCrunch

Mojo Vision announced a new prototype of its augmented reality contact lens technology

TGH and USF Health first in Florida to use newly developed heart implant - Vimarsana News

TGH and USF Health first in Florida to use newly developed heart implant

Tampa General is the second hospital in the country to perform the TricValve procedure and the only one to implant two patients.